drugset / Trial / NCT06587386

The Minimum Effective Dose (ED90) of Liposomal Bupivacaine for Preserving Motor Function

NCT06587386 ↗

Phase 4 Completed 55 enrolled Affiliated Hospital of Jiaxing University
RandomizedSequentialDouble-blindDiagnostic

Summary

Explore the minimum effective dose of liposomal bupivacaine for preserving motor function

Timeline

Start
2025-05-20
Primary completion
2025-11-10
Completion
2025-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 15 ml —
Subject Bupivacaine Other / unclassified 66.5 mg —

Indications